Presentation Details:
This presentation provided an update on antiretroviral therapies and began a discussion of difficult questions regarding ARVs. Topics included:
1) The best regimen for an M184V mutation;
2) Dolutegravir and its potential link to neural tube birth defects; and,
3) Weight gain on Dolutegravir or TAF.
Presentation Transcript: